A Clinicopathological study of Autoimmune Vesiculobullous Diseases by Subramania Adityan, M
A CLINICOPATHOLOGICAL STUDY OF AUTOIMMUNE 
VESICULOBULLOUS DISEASES 
Dissertation submitted 
in partial fulfillment for the Degree of 
DOCTOR OF MEDICINE
BRANCH – XII A 
M.D., (DERMATO VENEROLOGY)
MARCH 2007 
DEPARTMENT OF DERMATOLOGY 
MADURAI MEDICAL COLLEGE 
THE TAMILNADU DR. M.G.R. MEDICAL UNIVERSITY 
CHENNAI – TAMILNADU 
CERTIFICATE
This  is  to  certify  that  this  dissertation  entitled  “A CLINICOPATHOLOGICAL 
STUDY  OF  AUTOIMMUNE  VESICULOBULLOUS  DISEASES” submitted  by 
Dr.M. Subramania Adityan to The Tamil Nadu Dr. M.G.R. Medical University, Chennai is in 
partial  fulfillment of the requirement for the award of M.D. Degree  Branch XII A, M.D., 
(Dermato  Venerology) and  is  a  bonafide  research  work  carried  out  by  him under  direct 
supervision and guidance. 
Dr. S. Krishnan, M.D., D.D      Dr. H.Syed Maroof Saheb, M.D., D.D  
Additional Professor,      Professor and Head, 
Department of Dermatology,      Department of Dermatology,
Govt. Rajaji Hospital,      Govt. Rajaji Hospital, 
Madurai Medical College,      Madurai Medical College,
Madurai.      Madurai. 
     
ACKNOWLEDGEMENT
Gratitude cannot be expressed through words. True, but unexpressed gratefulness weighs 
heavily on one’s heart. I may be permitted here to record valuable guidance, help, co-operation 
and  encouragement  from  my  teachers,  colleagues  and  various  other  persons  directly  or 
indirectly involved in the preparation of this dissertation.
First of all I would like to acknowledge my thanks and sincere gratitude to our beloved 
Prof. Dr.H.Syed Maroof Saheb, Professor and Head of the department of dermatology, GRH 
& MMC, Madurai for his valuable advice and encouragement.
I  profoundly  thank  Dr.S.Krishnan, Addl.  Professor,  dept.  of  dermatology,  MMC & 
GRH, for his valuable guidance.  
I express my deep sense of gratitude and thanks to my teachers  Dr.A.S.Krishnaram, 
Dr.G.Geetharani,  and Dr.A.K.P.Vijayakumar  Assistant  Professors,  for  their  valuable 
guidance, timely advice, constant encouragement and easy approachability in the preparation of 
this  dissertation.  Their  profound  knowledge  in  dermatology  gave  me  immense  confidence 
throughout the study.
I  would  also  like  to  acknowledge  my  thanks  to  my  teachers  Dr.S.Ragunath  and 
Dr.K.Senthilkumar,  Assistant  Professors,  Department  of  Dermatology,  GRH  &  MMC, 
Madurai, for their constant support and encouragement.
I would like to express my thanks to Prof. Dr.Gomathinayagam, Professor and head of 
the department of pathology, MMC, Madurai.
I  owe thanks to the Dean,  Principal  and Medical Superintendent for allowing me to 
conduct this study.
I  owe  thanks  to  my  fellow  postgraduate  colleagues  for  their  constant  help  and 
constructive criticism.
I am thankful to the technicians of the pathology department. I also would like to thank 
the staff nurses for their help in biopsy procedures.
I owe a lot to my family, which has always stood by me my career.
I owe a lot to all my patients without whom this study would not have taken off, and the 
authors, who have worked on this subject, from whose wisdom and experience. I have been 
benefited immensely.
CONTENTS 
S.NO Particulars Page No.
1. Introduction 1
2. Review of literature 3
3. Aims of study 27
4. Materials and Methods 28
5. Observations and Results 30
6. Discussion 42
7. Summary 49
8. Conclusion 52
9. Bibliography 53
10. Annexures 
- Photographs 
- Proforma 
- Master Chart 
- Key to Master chart 
INTRODUCTION
Vesicles and bullae are reaction patterns of the skin to injury, and thus 
can be caused by a wide variety of conditions. Many skin diseases present 
with blisters,  but only in some of them does blistering occur as a primary 
event.  This  group  of  disorders  has  been  traditionally  termed  ‘the 
vesiculobullous disorders’. Most primary vesiculobullous diseases are either 
genetic  or  immunologic.  The  latter  group,  also  called  the  ‘autoimmune 
vesiculobullous diseases’ is the focus of this study.
The autoimmune vesiculobullous diseases are a heterogeneous group of 
diseases. They are classified on the basis of their clinical, histopathological,  
and  immunopathological  features.  Thus,  they  can  be  broadly  classified 
histopathologically  into  epidermal  and  subepidermal  blistering  dermatoses. 
These can be further categorized, based on their immunopathological features, 
into several individual diseases.
Though these disorders are rare in the general population, for a given 
patient, the impact of the diseases on the quality of life can be devastating. 
The severity is often variable and the course is unpredictable, and may even be 
fatal. Moreover, some auto immune vesiculobullous diseases may be markers 
for internal malignancy.
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Since  the  days  of  Walter  lever  who  differentiated  pemphigus  from 
pemphigiod, dramatic progress has been made in the understanding of these 
diseases,  with  the  advent  of  investigative  techniques  such  as  electron 
microscopy,  immunoprecipitation,  immunoblotting  and  molecular  genetic 
analysis.  In  the  therapeutic  front,  dexamethasone  cyclophosphamide  pulse 
therapy has improved the prognosis, and emerging therapies like biologicals 
hold much promise for the future.
But despite the explosion of knowledge regarding the etiopathogenesis, 
the  exact  mechanism that  triggers  autoimmunity  in  these  patients  remains 
largely unclear.
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HISTORICAL ASPECTS
Historical aspects of diseases 
1884 - Louis Duhring described Dermatitis Herpetiformis.
1894 - Piotr Vasiliyevich Nikolsky described Nikolsky sign 
1943 - Acantholysis first demonstrated as a characteristic feature 
of pemphigus bullae1. 
1947 - Cytology was introduced in skin disorders by Tzanck. 
1949 - Civatte separated cicatricial pemphigoid from  
pemphigus. 
1953 - Walter lever distinguished Pemphigus from pemphigoid2. 
1964 - Beutner and Jordan discovered circulating antibodies 
against cell surface of keratinocytes from the sera of 
pemphigus patients3. 
1967 - Beutner et al demonstrated anti basement membrane zone 
antibodies in bullous pemphigoid6. 
1973 - Roenigk et al proposed the clinical criteria for EBA. 
1975 - Chorzelski and Jablonska recognised LABD as a separate 
entity based on immuno pathologic findings.
1979 - Pemphigoid vegetans was first reported by Winkelmann 
R.K. and Su. W.P.
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1980 - Nieboer et al separated EBA from BP by immunoelection 
microscopy7.  
1982 - Stanley et al characterized the target antigens of 
pemphigus by immunoprecipitation and 
immunoblotting4. 
1990 - Paraneoplastic pemphigus was first recognised as a 
distinct entity by Anhalt et al. 
1991 - Amagai et al demonstrated that pemphigus is an anti-
cadherin autoimmune disease by isolation of the cDNA 
of pemphigus antigens5. 
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Epidemiology 
 The epidemiological  aspects of autoimmune vesiculobullous diseases 
are covered in the table below. 
Disease Incidence
Geographic 
pattern
Age M:F
HLA 
association
Pemphigus 
vulgaris & 
vegetans 
About 1.3 
per 
million 
per year 
Higher in Jews 
and people of 
Mediterranean 
origin 
Middle 
age 
M=F DR4 
(subtype) 
DQ1, 
Subtype 
DQB1, 0503 
DRB1(0402)
Pemphigus 
foliaceus 
.3 cases 
per 
million 
per year 
Higher in 
Brazil, Finland 
and Tunisia  
Middle 
age 
M=F
Fogo selvagum 3.4% on 
endemic 
areas of 
Brazil8 
Endemic 
around the 
rivers of Brazil 
Children 
and 
young 
adults 
DR1
Bullous 
pemphigoid 
7 per 
million9 
per year 
Worldwide Old age 
(few 
infants 
& 
children)
M=F DQB1*0301 
DQ7 (males)
Cicatricial 
pemphigoid 
1 per 
million 
per year 
No geographic 
predilection 
Middle 
old age 
F:M=2:1 DQB1*0301
Pemphigoid 
Gestationis 
1:170010
1:10,00011 
deliveries
- - Pregnant 
woman 
DRB1*0301, 
DRB1*0401, 
C4 null allele 
in 90%
Linear IgA 
Disease 
1. Childhoo
d 
2. Adults 
About 1 in 
2.5 
million 
per year12
”
Childhood 
variant more 
common in 
developing 
countries 
<5 yrs 
>40 yrs 
Slight female 
preponderance 
”
HLS –B8, 
TNF2 allele 
(76%)
HLA-B8 
(some) TNF-
2 allele 
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Disease Incidence
Geographic 
pattern
Age M:F
HLA 
association
EB acquisita 0.25 per 
million 
per year13
More 
common 
among 
Asians and 
African – 
Americans 
Adults 
(few 
children)
HLA –DR2
Bullous SLE 0.2 per 
million14
More 
common or 
African 
Hispanic 
descent 
Young 
adults 
F>M HLA DR2
Dermatitis 
herpetiformis 
1.3 per15 
million 
per year 
in 
Finland 
Common in 
North-
European 
descents. 
Rare in far 
east 
Middle 
age 
M:F =1.5:1 DQ1, 
DQB8, 
DQW2, 
DQ(α1*501)
DQ(α1*03)
In  an  Indian  study  by  Arya  et  al58,  pemphigus  vulgaris  was  the 
commonest vesiculobullous disease, comprising 61.4% of the cases studied, 
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followed by pemphigus foliaceus. 
In the study by K.K.Das et al57, pemphigus vulgaris was the commonest 
40.8%, followed by dermatitis herpetiformis 36.2%, bullous pemphigoid 16%, 
CBDC 5.3% and Hailey-Hailey disease 1.4%. 
Etiopathogenesis 
The etiopathogenisis of various autoimmune vesiculobullous diseases 
are summarised in the table given below:
Disease
Antibody 
isotype 
Target 
antigen 
Antigen 
KDa
Epitope Location 
Pemphigus 
vulgaris/ 
vegetans 
IgG (few 
IgM, 
IgA)
Desmoglein3 
Desmoglein1
130KDa
160KDa
Amino terminal 
of extracellular 
domain 
Desmosome 
Pemphigus 
foliaceus 
IgG Desmoglein1 160KDa ” ”
IgA 
pemphigus 
IgA1 Desmocollin1 - Desmosome 
Fogo 
selvagum 
IgG Demoglein1 160KDa Aminoterminal 
of extracellular 
domain 
Desmosome 
Bullous 
pemphigord 
IgG (few 
IgA)
BPAG1
BPAG2
230KDa
180KDa
α-helix 
terminal 
regions 
Non 
collagenous 
region just 
Hemidesmosome 
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outside the 
membrane 
Cicatrical 
pemphigoid 
IgG, IgA BPAG1
BPAG2
Laminin 5
β4 integrin 
20KDa
180KDa
600KDa
205KDa
?
Distal extra 
cellular domain 
α-submit 
- 
Hemidesmosome 
anchoring 
filament 
” 
”
Pemphigoid 
vegetan
IgG4 BPAG1 230 
KDa
- Hemidesmosome 
Pemphigoid 
gestationis 
IgG BPAG1
BPAG2
230KDa
180KDa
?
Transmembrane 
Hemidesmosome 
Linear IgA 
dermatosis 
(both 
childhood & 
adult)
IgA 97KDa
120KDa
285KDa
Soluble 
ectodomain of 
BPAG2
”
?
Anchoring 
filament 
”
?
EB acquisita IgG Type VII 
collagen 
290KDa Fibronectin like 
region of NC1 
domain 
Anchoring fibril
Bullous SLE IgG, IgA ” ” ” (some) Anchoring fibril 
Dermatitis 
herpetiformi
s 
IgA Unknown - - Upper dermis 
In a recent Indian study by Bhushan Kumar et al64, it has been reported 
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that the titre of antibodies against desmoglein-1 correlated with the severity of 
the skin disease, and anti desmoglein-3 antibody titre correlated well with oral 
lesions of pemphigus vulagris.  However,  anti  demoglein 3 antibodies were 
found in detectable levels in all patients with pemphigus foliaceus, apart from 
anti desmoglein-1 antibody.  
Clinical features 
The  clinical  features  of  the  various  autoimmune  vesiculobullous 
diseases are summarised in the tabular column given below: 
Disease
Cutaneous 
distributio
n 
Mucosal 
involvement 
Pattern of skin 
lesions 
Scarring 
Disease 
association 
1. Pemphigus 
vulgaris 
Scalp, face 
flexures 
may be 
generalised 
Common 
orpharynx, 
conjunctiva 
genitalia 
Flaccid blisters, 
erosions show 
no tendency to 
heal, nikolsky 
sign & bulla 
spread sign +ve, 
flexural 
vegetations 
- Other auto 
immune 
disease, 
thymoma. 
Rarely BP45, 
may evolve 
into 
P.foliaceus & 
vice vasa 
2. Pemphigus 
vegetans 
Flexural Oral Vesicles, 
pustules, 
erosions, 
vegetating 
plaques 
- -
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3. Pemphigus 
foliaceus 
Scalp, face, 
chest, upper 
back 
(seborrheic) 
may be 
generalised 
- Scaly papules, 
crusted erosions, 
erythroderma 
- -
4. Epidemic 
pemphigus 
foliaceus 
Head, neck, 
generalised 
Uncommon Flaccid blisters, 
erosions, 
verrucous 
lesions, 
erythroderma 
- -
5. Bullous 
pemphigoid 
Trunk, 
limbs 
flexures 
Common, 
minor
Urticated 
plaques, tense 
blisters, milia 
- -
6. Cicatrical 
pemphigoid 
Infrequent 
(30%)
Major, severe 
desquamative 
gingivitis 
conjunctivitis 
scarring, 
symble 
pheron 
Tense blisters, 
erosions milia 
+++ Autoimmune 
diseases 
7.Pemphigoi
d gestationis 
Umbilicus, 
generalised  
Minor Urticated 
plaques, tense 
blisters 
- Autoimmune 
thyroid 
disease 
8. Linear IgA 
dermatosis 
1. CDBC 
2. Adult LAD 
Perineum, 
face trunk, 
limbs
Trunk, 
limbs  
Majority 
(few severe) 
”
Majority 
(few severe)
Urticated 
plaques, annular 
lesions, 
Urticated 
plaques, tense 
blisters milia 
+ 
+
Ulcerative 
colitis 
lymphoma 
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9. EB 
acquisita 
Variable 
generalised 
Some
(few severe)
++ Inflammatory 
bowel 
disease 
10. Bullous 
SLE
Variable, 
generalised 
Minor Urticated 
plaques tense 
blisters 
- SLE
11. 
Dermatitis 
herpetiformis 
Elbows, 
knees, 
buttocks 
symmetrical 
Minor Papulovescicles 
excoriations 
- gluten 
sensitive 
exteropathy, 
lymphoma 
CYTODIAGNOSIS OF AUTOIMMUNE 
VESICULOBULLOUS DISORDERS
Tzanck  smear is  a  rapid  preliminary  test  used  in  the  diagnosis  of 
blistering diseases. A smear is made from the floor of a freshly opened vesicle. 
It is allowed to dry and flooded with equal quantity of water and Giemsa or 
Leishman’s  stain.  After  30-40  seconds,  the  slide  is  rinsed,  air-dried,  and 
examined for acantholytic cells.
Acantholytic cells           
An  acantholytic  cell  is  rounded,  with  an  enlarged  nucleus  with 
peripheral  condensation  of  chromatin  and  prominent  nucleoli.  There  is  a 
perinuclear halo, with the peripheral parts of the cell staining more darkly. In 
older cells the nucleus may be pyknotic.
In pemphigus vulgaris and vegetans, typical, rounded acantholytic cells 
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are seen. In pemphigus foliaceus and pemphigus erythematosus, cells tend to 
be  cuboidal,  with  a  small  nucleus  and  more  prominent  cytoplasm. 
Keratohyaline  granules  and  evidence  of  keratinisation  may  be  seen. 
Occasional multinucleated cells may be seen69. 
Eosinophils  are  commonly  seen in  bullous  pemphigoid,  but  may be 
seen in dermatitis herpetiformis also.
Histopathology in autoimmune vesiculobullous diseases
1) Pemphigus vulgaris 
A small, early vesicle is preferable. Scalpel biopsy of the intact blister 
should be done. If punch biopsy is to be done, the lesion should be frozen by a 
refrigerant spray. If no new blister is seen, an old one may be moved to the 
neighbouring skin by finger. The new cleavage reveals early specific changes.
Early lesions show eosinophilic spongiosis in the lower epidermis. This 
is  a  manifestation  of  acantholysis,  rather  than  true  spongiosis.  Developed 
lesions  show  clefts  and  suprabasal  blisters.  Acantholysis  extends  to  the 
adnexal structures.
The  basal  keratinocytes  are  detached  from  each  other,  but  remain 
attached to the basement membrane, because the hemidesmosomes are intact. 
This gives an appearance of ‘row of tombstones’.
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As  the  blister  ages,  a  mixed  inflammatory  infiltrate  appears  in  the 
dermis. There may be epidermal downgrowth or villi.
In  patients  with  only  oral  erosions,  DIF  from  the  perilesional  oral 
mucosa is more sensitive than lesional biopsies for HPE.
2) Pemphigus Vegetans
a)  Neumann  type  :  Early  lesions  have  the  same  histopathology  as 
pemphigus vulgaris. Later, there is formation of villi and verrucous epidermal 
hyperplasia.  Eosinophilic  spongiosis  and  eosinophilic  pustules  are  present. 
Acantholysis may be absent in older lesions.
b) Hallopeau type : Early lesions have suprabasal clefts with plenty of 
eosinophils. There are more eosinophilic abscesses than Neumann type20.
3) Pemphigus foliaceus
There is acantholysis in the granular layer, leading to subcorneal cleft 
and detachment  of  str.corneum. The number  of  acantholytic  cells  is  small. 
There may be eosinophilic spongiosis. Dyskeratotic granular keratinocytes are 
diagnostic.
4) Pemphigus erythematosus
Histology similar to pemphigus foliaceus. Interface dermatitis may be 
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seen in rare cases21.
5) Ig A pemphigus
a) SPD type : There are subcorneal vesiculopustules with minimal 
    acantholysis 
b) IEN type : Has intraepidermal vesiculo pustules with neutrophils
6) Paraneoplastic pemphigus
Variable.  EMF-like,  LP-like,  pemphigus  –  like  and  Bullous 
pemphigoid-  like  features  may  be  seen.  PNP may  present  with  lichenoid 
interface dermatitis without acantholysis22.
7) Bullous pemphigoid
The blister arises at the dermo epidermal junction23. Two patterns are 
seen.
Blisters  arising  on  as  erythematous  base  show  a  cell-rich  pattern. 
Eosinophilic papillary abscesses may develop,  along with lymphocytes and 
neutrophils  in  superficial  and  deep  demis.  Eosinophilic  spongiosis  may 
occur24.
Blisters on a clinically normal skin show cell poor pattern, with a scant 
perivascular lymphocytic infiltrate, with some eosinophils24. 
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8) Pemphigoid gestationis
There  is  eosinophilic  spongiosis,  papillary  dermal  edema  and  a 
perivascular  infiltrate  of  lymphocytes  and  eosinophils25.  Focal  necrosis  of 
basal keratinocytes leads to subepidermal blister26.
9) Cicatricial pemphigoid
The  subepidermal  bulla  extends  down  the  adnexa.  Neutrophils, 
lymphocytes and histiocytes predominate in the infiltrate. Eosinophils may be 
present. Lamellar fibrosis beneath the epidermis is the hallmark.
10)  Linear  IgA dermatosis
Features are similar to dermatitis herpetiformis. A subepidermal blister 
with  neutrophils  and  fibrin  in  the  lumen  is  seen.  Early  lesions  show 
neutrophils  concentrated  in  the  dermal  papillae  and  lined  along  the 
dermoepidermal junction.
11) Epidermolysis bullosa acquisita
        In the commonest type (bullous pemphigoid-like), sub epidermal blisters 
with lymphocytes and neutrophils are seen. Eosinophils are variable. In the 
classical form, non-inflammatory subepidermal blisters with fibrosis and milia 
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formation are seen.
12) Bullous SLE            
Three patterns may be seen 
a) Most common is the DH-like pattern
b) Second pattern (25%) is subepidermal blister with a neutrophil  – 
rich leukocytoclastic vasculitis27
c) Third pattern is severe basilar vacuolation with subsequent blister 
formation.
13) Dermatitis herpetiformis
Typical features are seen in perilesional erythematous skin. Neutrophils 
accumulate in the tips of the dermal papillae28. Early blisters are multilocular, 
which later become unilocular. Apoptotic keratinocytes may be seen above the 
miroabscesses.
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DIRECT IMMUNOFLUORESCENCE IN 
VESICULOBULLOUS DERMATOSES
Procedures   
 A 3-4mm punch biopsy from the inflamed, but unblistered perilesional 
skin is preferred.
 If there is a delay of more than 24 hrs before processing, the specimen 
should be kept in Michel’s medium, which contains.
5% Ammonium sulphate 
Magnesium sulphate
N – ethyl maleimide (K+ inhibitor)
Citrate buffer (pH 7.25) 
 Specimens  may  be  kept  in  Michel’s  medium for  2  weeks  at  room 
temperature and for several weeks in refrigerator.
 While  processing,  the  specimen  is  washed,  embedded  in  OCT 
(optimized  cutting  temperature)  compound,  and  snap  frozen.  6µ 
sections are made, and incubated with antihuman IgG, IgM, IgA and 
C3,  which  are  tagged  with  fluorescein  isothiocyanate.  Sections  are 
visualised in fluorescent microscope29.
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Salt Split Skin
 The human skin is split at the level of lamina lucida when incubated for 
48-72  hrs  1M Nacl.  If  it  is  used  as  substrate  DIF  and  IIF  studies 
become more  sensitive30 and  differentiation  of  subepidermal  bullous 
diseases is possible.
DIF Patterns
1) Pemphigus Vulgaris
 Squamous intercellular IgG in upto 100%31, in a chicken 
wire pattern
 DIF remains positive for many years after the clinical 
disease has subsided32.
 False positive tests may be seen in spongiotic dermatitis, 
psoriasis and insulation of serum.    
2) Pemphigus vegetans  
Squamous intercellular IgG present in all reported cases33 .
3) Pemphigus foliaceus     
Two patterns have been described commonly, full thickness squamous 
inter cellular IgG is seen. Rarely IgG may be localised to the upper layers34.
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4) Pemphigus erythematosus
Squamous intercellular IgG seen in >75% of cases, along with deposits 
of IgM and IgG (positive lupis band) in the DEJ.
5) Ig A Pemphigus
Reveals  squamous  intercelleular  IgA  throughout  the  epidermis. 
Complement and other Igs are usually absent35. Some cases show both IgA 
and IgG36.
6) Paraneoplastic Pemphigus 
 Squamous intercellular IgG is seen along with granular deposits of C3 
in the dermoepidermal junction37. Linear deposits of C3, IgG, IgM or granular 
deposits of IgG and C3 may also be seen along the BMZ38.  
7) Bullous pemphigoid
Linear BMZ deposits of C3 seen in upto 100% of cases, IgG is seen in 
65-95% of cases39.  IgA and IgM are seen in 25% of cases. 
8) Pemphigoid gestationis 
Linear BMZ deposits of C3 is seen in 100% of cases40. IgG is seen in 
30-40% of cases. 
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9) Cicatricial pemphigoid 
Linear BMZ IgG and C3 are seen in 80% of cases. Mucous membrane 
is the preferred site for DIF studies41. Salt splitting increases the sensitivity 42. 
10) Linear IgA dermatosis 
Linear BMZ IgA, deposits seen in 100% of cases43. In the lamina lucida 
type, IgA is seen on the epidermal side of the salt split skin. In the sublamina 
dense  type,  IgA,  localizes  to  the  dermal  side.  This  type  has  now  been 
classified as IgA mediated EBA.  
11) Epidermolysis bullosa acquisita 
Linear BMZ deposits of C3, IgG and less commonly IgM and IgA are 
seen.  Increasing  number  of  immunoreactants  along  the  BMZ  favours  a 
diagnosis of EBA over bullous pemphigoid. In salt split skin, IgG is seen on 
the floor of the split44. 
12) Bullous SLE 
IgG and C3 are seen in 100% of cases in the BMZ. In 50% of cases the 
pattern is linear and in 25% it is granular. IgM and IgA are seen in 50% and 
60% of cases, respectively. 
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13) Dermatitis herpetiformis 
Granular deposits of IgA can be seen within the dermal papillae45. False 
negative results may occur if inflamed lesions are biopsied46. DIF results are 
not altered by dapsone therapy. 
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INDIRECT IMMUNOFLUORESCENCE
IIF is a semiquantitative procedure in which double immunolabelling is 
done  to  evaluate  the  presence  and  titre  of  circulating  antibodies,  or  to 
specifically localise an antigen in the skin. 
Procedure  
The serum is serially diluted. The substrates most commonly used are
a. Monkey esophagus – pemphigus vulgaris46
b. Guinea pig esophagus – pemphigus foliaceus47
c. Human salt split skin – subepidermal blistering diseases 
d. Murine bladder epithelium – paraneoplastic pemphigus  
The serially diluted serum is incubated with the substrate for 30 mins at 
room temperature and washed. Antibodies bound to the substrate are detected 
by incubation with FITC-labelled goat antihuman IgA or IgG. 
IIF PATTERNS 
1. Pemphigus vulgaris
>80% have circulating anti cell surface IgG48. There is a positive, but 
imperfect  correlation  between  the  antibody  titre  and  disease  activity49  in 
pemphigus vulgaris and pemphigus foliaceus. 
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2. Pemphigus foliaceus 
Squamous intercellular IgG deposits seen in 80-90% of cases. 
3. Pemphigus erythematosus 
Using monkey esophagus, IIF reveals ICS deposits of IgG in 80% of 
cases ANA is positive in 30-80% of cases. 
4. IgA pemphigus 
Positive in less than 50%50 of cases. 
5. Paraneoplastic pemphigus 
Circulating antibodies that bind to rat bladder epithelium is seen in all 
cases.  Immunoblotting  and  immunoprecipitation  are  more  sensitive  and 
specific, and at a minimum, antibodies to envoplakin and periplakin should be 
demonstrated51. 
6. Bullous pemphigoid 
Positive in 70-80% of cases. Titres have poor correlation with disease 
activity. In salt split skin, antibodies bind to roof alone (80%) or roof and floor 
(20%). 
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7. Pemphigoid gestationis 
Using in vitro complement fixation, anti BMZ IgG is seen in virtually 
all patients.  
8. Cicatricial pemphigoid 
In salt split skin, IgG and / or IgA binds usually to the epidermal side, 
although combined pattern and dermal binding can also occur. 
9. Linear IgA dermatosis 
Using salt split  skin, low titre IgA is demonstrated in most cases of 
CDBC and LAD52. 
10. EB acquisita 
50% of cases show anti BMZ zone antibodies, localised to the floor of 
salt split skin53. 
11. Bullous SLE 
Circulating anti BMZ antibodies are rare.  However,  salt  split  studies 
increase the sensitivity and antibodies localize to the floor of the split54. 
12. Dermatitis herpetiformis 
Using monkey or pig gut as substrate, circulating anti-endomysial IgA 
can be seen in 50-100% of cases. Anti reticulin, anti gluten, anti bovine serum 
albumin and anti lactoglobulin antibodies may also be present. 
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OTHER DIAGNOSTIC METHODS 
ELISA 
In  pemphigus,  antigen  specific  ELISA has  been  shown  to  be  more 
sensitive, specific and to correlate with disease activity better than IIF55.  
Immunoperoxidase  methods  have  roughly  the  same  sensitivity  as 
immunofluorescence studies56. 
Immunoprecipitation and immunoblotting 
They detect antigens as protein bands of different molecular weights 
separated  by  electrophoresis.  Immunoblotting  requires  denaturation  of 
substrates,  whereas  immunoprecipitation  does  not.  The  former  recognizes 
antibodies against linear epitopes while the latter recognizes antibodies against 
conformational epitopes. Immunoblot is easier because immunoprecipitation 
requires radiolabelling. 
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AIMS OF THE STUDY
This study of autoimmune vesiculobullous diseases was undertaken. 
1. To  find  out  the  presence  of  different  autoimmune  vesiculobullous 
diseases and their incidence encountered among patients attending skin 
OPD. 
2. To  find  out  the  various  morphological  patterns,  symptoms,  and 
systemic association if any. 
3. To  correlate  the  clinical,  cytological,  histopathological  and 
immunofluorescence features of various autoimmune vesiculobullous 
diseases. 
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MATERIALS AND METHODS
The material  for  this  study was from the patients  attending the skin 
OPD, Government Rajaji Hospital, Madurai Medical College, Madurai, with 
autoimmune  vesiculobullous  diseases  of  the  skin  during  the  period  of 
May 2004 – May 2006. 
In total  40 patients  with vesiculobullous lesions were subjected to  a 
detailed  clinical  evaluation,  followed  by  cytological,  hispathological  and 
direct immunofluorescence studies. Out of this 40 cases, 32 were confirmed as 
cases of autoimmune vesiculobullous diseases, and were included in the study 
after  getting  informed  consent.  The  remaining  8  cases  whose  cytology, 
histopathology and immunofluorescence  were  found to  be  otherwise,  were 
excluded from the study. 
A detailed history was elicited with particular reference to the age of 
onset,  duration,  site,  morphology  of  lesions,  progression,  symptoms, 
occupation, and family history. 
Thorough  general,  systemic  and  dermatological  examinations  were 
done. 
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Routine  laboratory  investigations  like  blood  for  Hb%,  TC,  DC and 
ESR,  urine  examination  for  albumin,  sugar  and  microscopy,  and  special 
investigations  like  x-ray  chest,  ultrasonogram,  and  CT of  abdomen,  were 
performed wherever necessary. 
Tzanck  smear  was  done  in  every  patient.  The  smear  was  air  dried 
stained with Leishman’s stain and studied. 
Skin  biopsies  were  taken  after  informed  consent.  After  thorough 
cleaning of the selected part with spirit or povidone –iodine solution, the area 
was  infiltrated  with  2% lignocaine  and  a  bit  of  skin  involving  the  whole 
thickness  was  removed by elliptical  incision  method.  The  specimens  were 
preserved in 10% formalin and submitted to histological section of pathology 
department, Madurai Medical College. Specimens were studied with routine 
H&E stain. For direct immunofluorescence studies, after careful selection of 
the part to be biopsied, biopsy was done as described above and the specimen 
was preserved in  Michel’s  medium and sent  to  the Department  of  Skin & 
STD, Kasturba Hospital, Manipal. 
Indirect  immunofluorescence  test  was  done  wherever  necessary,  to 
arrive at the correct diagnosis. 
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OBSERVATIONS & RESULTS
 In  this  study,  32  cases  of  autoimmune vesiculobullous  disease  were 
studied from the outpatient department of dermatology, Govt. Rajaji hospital, 
Madurai  medical  college,  Madurai  from  May  2004  to  May  2006.  The 
following observations were made.
The various autoimmune vesiculobullous diseases encountered were 
Disease No. of 
Patients
Percentage (%)
Pemphigus vulgaris 13 42%
Bullous pemphigoid 8 25%
Pemphigus foliaceus 2 6%
Pemphigus erythematosus 3 9%
Bullous SLE 1 3%
ACLE 1 3%
Linear IgA dermatosis  2 6%
Pemphigoid Vegetans 1 3%
IgA pemphigus 1 3%
Total 32 100%
     
Pemphigus  vulgaris  was  the  most  common  vesiculobullous  disease 
(42%) followed by bullous pemphigoid (25%) pemphigus foliaceus (6.25%), 
pemphigus erythematosus  (9.3%),  bullous  SLE(3%),  acute  cutaneous lupus 
erythematogus  (3%)  linear  IgA dermatosis  (6.25%),  pemphigoid  vegetans 
(3%) and IgA pemphigus (3%) were the other diseases seen. 
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Pemphigus vulgaris Bullous pemphigoid 
Pemphigus foliaceus Pemphigus erythematosus 
Bullous SLE ACLE
Linear IgA dermatosis  Pemphigoid Vegetans 
IgA Pemphigus 
AGE DISTRIBUTION 
The age of onset of various diseases were 
Age of 
onset
PV BP PF PE LAD BSLE ACLE PgV IgAP TOTAL
0-10 - - - - - - - - - -
11-20 - - 1 - 1 1 - - - 3
21-30 1 2 - 1 - - - - - 3
31-40 5 1 - - - - - - - 6
41-50 4 2 - 1 1 - - - - 6
51-60 3 1 1 - - - 1 1 - 7
61-70 - 2 - 1 - - - - - 3
>71 - - - - - - - - 1 1
Total 13 8 2 3 2 1 1 1 1 -
PV = Pemphigus vulgaris BSLE = Bullous SLE
BP = Bullous pemphigoid ACLE = Acute cutanoues LE
PF = Pemphigus foliaceus PgV = Pemphigoid vegetans 
PE = Pemphigus erythematosus IgAP = IgA pemphigus
LAD = Linear IgA dermatosis 
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According to our study, the mean age of onset for pemphigus vulgaris 
was  42,  and  that  for  other  diseases  were  bullous  pemphigoid  51  yrs, 
pemphigus foliaceus 36 yrs, pemphigus erythematosus 46 yrs, LAD 35 yrs, 
ACLE 52  yrs,  bullous  SLE 18  yrs,  pemphigoid  vegetans  60  yrs  and  IgA 
pemphigus 75 yrs.  
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SEX DISTRIBUTION 
In  our  study,  the  male:  female  ratio  for  individual  diseases  were  as 
follows:
Disease Total Male Female M:F
Pemphigus vulgaris 13 4 9 1:2
Pemphigus foliaceus 2 1 1 1:1
Pemphigus erythematosus 3 2 1 2:1
Bullous pemphigoid 8 3 5 3:4
LAD 2 2 - -
Bullous SLE 1 - 1 -
ACLE 1 - 1 -
Pemphigoid vegetans 1 1 - -
IgA pemphigus 1 - 1 -
Total 32 13 19 2:3
Duration 
The mean duration of disease was 1.7 years, with a maximum of 15 yrs, 
and a minimum of 1 month. 
Distribution 
The distribution of lesion in the various diseases were as follows
Region PV PF PE BP LAD ACLE BSLE PgV IgAP
Scalp 10 2 3 1 1 - - 1 -
Face 10 2 3 3 2 1 1 1 -
Trunk 13 2 3 8 2 1 1 1 1
Limbs 13 2 - 8 1 - 1 1 -
Flexures 7 - - 8 - - - 1 1
Seborrheic 
distribution 
- - - - - - -
PV = Pemphigus vulgaris BSLE = Bullous SLE
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BP = Bullous pemphigoid ACLE = Acute cutanoues LE
PF = Pemphigus foliaceus PgV = Pemphigoid vegetans 
PE = Pemphigus erythematosus IgAP = IgA pemphigus
LAD = Linear IgA dermatosis 
Mucosal involvement  
The pattern of mucosal involvement was as follows 
Mucosa PV PF PE BP LAD ACLE BSLE PgV IgAP
Oral 13 - - 4 2 1 1 - -
Conjuctival 2 - - - 1 - - - -
Genital 4 - - - - - - - -
PV = Pemphigus vulgaris BSLE = Bullous SLE
BP = Bullous pemphigoid ACLE = Acute cutanoues LE
PF = Pemphigus foliaceus PgV = Pemphigoid vegetans 
PE = Pemphigus erythematosus IgAP = IgA pemphigus
LAD = Linear IgA dermatosis 
The mucosal involvement was severe in all  patients with pemphigus 
vulgaris, and preceded the skin lesions by a mean duration of 2 months. 
Mild to moderate involvement of oral mucosa was seen in 4 of the 8 
patients with Bullous pemphigoid (50%).
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Morphology of the lesions 
The various morphological patterns observed and their incidence in the 
diseases encountered are tabulated against the clinical diagnosis. 
Lesion PV PF PE BP LAD ACLE BSLE PgV IgAP
Flaceid blister 13 2 3 - - - - - 1
Flaccid blister 
with scaling 
- 2 3 - - - - - -
Tense blister - - - 8 2 1 1 1 -
Targetoid 
lesion 
- - - 5 - - - - -
Annular lesion - - - - 1 - - - -
Hypopyon - - - - - - - - 1
Scarring - - - - 1 - - - -
Milia - - - - - - - - -
PV = Pemphigus vulgaris BSLE = Bullous SLE
BP = Bullous pemphigoid ACLE = Acute cutanoues LE
PF = Pemphigus foliaceus PgV = Pemphigoid vegetans 
PE = Pemphigus erythematosus IgAP = IgA pemphigus
LAD = Linear IgA dermatosis 
Signs 
Nikolsky sign and Asboe-Hansen sign were elicited, and the results are 
given below, against the respective clinical diagnosis. 
Sign PV PF PE BP LAD BSLE BSLE PgV IgAP
Nikolsky sign 11 2 1 1 - - - - 1
Asboe-Hansen 
sign 
11 2 1 1 - - - - 1
PV = Pemphigus vulgaris BSLE = Bullous SLE
BP = Bullous pemphigoid ACLE = Acute cutanoues LE
PF = Pemphigus foliaceus PgV = Pemphigoid vegetans 
39
PE = Pemphigus erythematosus IgAP = IgA pemphigus
LAD = Linear IgA dermatosis 
Cytology 
The findings of tzanck smear examination of the different patients is 
summarised below, under their respective clinical diagnosis. 
Finding PV PF PE BP LAD BSLE ACLE PgV IgAP
Acantholytic 
cell
13 2 3 - - - - - -
MNGC (few) 3 - - - - - - - -
Eosinophils - - - 6 - - - 1 -
Neutrophils - - - - 2 1 - - 1
PV = Pemphigus vulgaris BSLE = Bullous SLE
BP = Bullous pemphigoid ACLE = Acute cutanoues LE
PF = Pemphigus foliaceus PgV = Pemphigoid vegetans 
PE = Pemphigus erythematosus IgAP = IgA pemphigus
LAD = Linear IgA dermatosis MNGC = Multinucleated giant cell
The multinucleated giant cells were few in number and were smaller, 
and had fewer nuclei than those seen in viral infections. 
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Histopathology 
The histopathology of the different patients with their respective clinical diagnosis in shown below:
Region Feature PV PF PE PV/BP BP LAD ACLE BSLE PgV IgAP CP
Epidermis
Subcorneal 
bulla 
- 2 3 - - - - - - 1 -
Suprabasal 
bulla 
13 - - - - - - - - - -
Dyskeratotic 
cells 
- 1 0 - - - - - - - -
Eosinophils 4 - - - 2 - - - - - -
Neutrophils 2 - - - - - - - - 1 -
Basal 
vacuolopathy 
- - 3 - - - 1 - - - -
Others - - - - - - Spongiosis 
(1)
- Epidermal 
hyperplasia 
(1)
- -
Dermis
Subepidermal 
bulla 
- - - 1 8 1 1 1 1 - 1
Hemorrhage - - - 1 2 - - - - - -
Eosinophils - - - - 8 - - - 1 - -
Neutrophils - - - - 1 1 - 1 - - 1
Lamellar 
fibrosis 
- - - - - - - - - - 1
Vasculitis - - - - - - - 1 - - -
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Part Immunoreactant PV PF PE PV/BP BP LAD ACLE BSLE PgV IgAP1 2
I
C
S
IgG Strong   11 2 3 1 - - - - - - -Weak 1 - - - - - - - - - -
C3 Strong  4 - 2 1 - - - - - - -Weak 2 2 1 - - - - - - - -
IgA - - - - - - - - - - 1
IgM - - - - - - - - - - -
B
M
Z
C3 Linear - - 2 - 1 8 1 - - 1 -Granular - - - - - - 1 1 1 - -
IgG Continuous - - - - - 6 1 - 1 - -Discontinuous - - - - - 2 1 1 - - -
IgA - - - - - 1 2 - 1 - -
Fibrinogen Continuous - 2 - - 2 1 - - - -Discontinuous 1 - - - - - 1 - - - -
IgM Continuous - - 2 - - - 1 - 1 - -Discontinuous - - - - - - - 1 - - -
Vessel wall IgM 
fibrogen
- - - - - C3 
IgM
- -
PV = Pemphigus vulgaris BSLE = Bullous SLE BP = Bullous pemphigoid 
ACLE = Acute cutanoues LE PF = Pemphigus foliaceus PgV = Pemphigoid vegetans 
PE = Pemphigus erythematosus IgAP = IgA pemphigus LAD = Linear IgA dermatosis 
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DISCUSSION
The study was conducted during the period May 2004 – May 2006 at 
the  Department  of  Dermatology,  Govt.  Rajaji  Hospital,  Madurai  Medical 
College, Madurai. 
Incidence  
32  cases  of  autoimmune  bullous  diseases  were  diagnosed  in  about 
1,92,750 patients who attended the skin OPD during the period of study.  
In  our study,  pemphigus vulgaris  was the commonest disease (42%) 
followed  by  Bullous  pemphigoid  (25%),  pemphigus  erythematosus  (9%), 
pemphigus foliaceus (6%) and linear IgA dermatosis (6%). K.K.Das (IJDVL – 
2003, vol-69, issue-1)57,  in his study, also reported that pemphigus vulgaris 
(40.8%) was the commonest. However dermatitis herpetiformis (36%) which 
was the next common in their study, was not encountered in our study. This 
may be due to geographic variation in the incidence. However, larger studies 
are required to settle the issue. 
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Age distribution 
Majority (78.1%) of the patients were between 21-60 yrs of age. This is 
in concordance with the study by Arya et al58, who recorded 80% in that age 
group. 
Sex distribution 
 In our study, the male:female is approximately 2:3. In the study by Arya 
et  al,  the  ratio  is  1.4:1.  Thus,  our  study  shows  an  increased  incidence  in 
women, especially in pemphigus vulgris, where the male:female ratio is 1:2. 
In the world literature, the incidence is accepted to be equal to both the sexes 
for pemphigus, and slightly higher in females for bullous pemphigoid. 
Extraordinarily  high  prevalence  of  pemphigus  in  females  has  been 
reported in certain countries. For example, in the study by Shafi M et al65, in 
libya, published in IJDVL, the female:male ratio for pemphigus vulgaris was 
90:19, and 100% of the pemphigus foliaceus patients were female.  
Morphology and distribution 
The morphology of lesions and their distribution in our series followed 
the pattern seen in earlier studies59,60,61. However, involvement of oral mucosa 
was seen in 100% of the pemphigus vulgaris patients, as against 72% reported 
by  Arya  et  al.  Neither  of  our  patients  with  pemphigus  foliaceus  had  oral 
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mucosal involvement (0%), as against 12% reported by Arya et al. All 3 cases 
(100%) of pemphigus erythematosis showed involvement of the malar area. 
Flexural  involvement  was  noted  in  6  of  the  8  cases  (75%)  of  bullous 
pemphigoid, as described in earlier studies. 
Clinical signs 
 Nikolsky sign and Asboe-Hansen sign were positive in all the cases of 
pemphigus, (100%) and one patient with paraneoplastic Bullous pemphigoid. 
In their series, Arya et al reported positive Nikolsky sign in 97.2% cases of 
pemphigus vulgaris and 94.7% cases of pemphigus foliaceus. The presence of 
positive  Nikolsky  sign  in  bullous  pemphigoid  is  well  documented,  in  the 
literature.  
Tzanck smear 
 Acantholytic  cells  were  seen  in  100%  of  the  cases  of  pemphigus 
vulgaris,  pemphigus  foliaceus  and  pemphigus  erythematosus.  Arya  et  al 
reported  acantholytic  cells  in  96%  of  cases  of  pemphigus  vulgaris  and 
foliaceus. Multinucleated cells were seen in 3 of the 13 patients (23%) with 
pemphigus vulgaris, in concordance with the study by Barr et al69. Eosinophils 
were seen in 75% of Bullous pemphigoid cases. The correlation between the 
presence of multinucleated giant cells and coexistant herpes simplex infection, 
and its implication in the prognosis, needs further study. 
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Histopathology 
Suprabasal bulla was seen in 100% cases of pemphigus vulgaris. Arya 
et al, in their study, reported 81.4% suprabasal bulla and 18.6% mid dermal 
bulla.  The  later  was  seen  in  older  bullae  due  to  regeneration.  Since  early 
blisters were carefully chosen for biopsy in our study, mid dermal bulla was 
not seen. 
An inflammatory infiltrate was seen in 46.1% of pemphigus patients, 
against 53.5% reported by Arya et al. Eosinophils were seen in 30.7% and 
neutrophils in 15.3% in our study, against 25.6% and 20.9% respectively, in 
the study by Arya et al. 
In pemphigus foliaceus, subcorneal bulla was seen in 100% of cases, as 
against 60% of cases in the study by Arya et al. Dyskeratotic cells were seen 
in one of the two patients (50%), whereas, only 8% of the cases showed the 
same in the study by Arya et al. 
 Subepidermal bulla (100%) and eosinophils  (100%),  were the most 
consistent findings in Bullous pemphigoid, in our study, which is concordant 
with earlier studies23. 
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Lamellar  fibrosis  of  the  dermis  was  seen  in  a  patient  of  LAD, 
presenting as cicatricial pemphigoid. 
Direct immunofluorescence 
The  direct  immunofluorescence  findings  in  our  series  were  in 
concordance  with  those  described  in  earlier  studies.  Intercellular  cement 
substance deposits (100%) and linear C3 BMZ deposits (100%) were the most 
consistent  findings  seen  in  pemphigus  vulgaris  and  Bullous  pemphigoid 
respectively. 
In  a  50  yrs  old  male  patient  who had been diagnosed as  a  case  of 
cicatricial  pemphigoid  based  on  clinical  features  and  histopathology,  the 
diagnosis was revised after the DIF showed a strong linear IgA band in the 
basement membrane zone, along with weak C3 deposits. The patient showed 
good response to dapsone therapy. This emphasises the importance of DIF, in 
the diagnosis,  and thereby, its  value in determining the therapy and hence, 
prognosis of autoimmune bullous disorders. 
Indirect immunofluorescence 
A 36  yr  old  female  presented  initially  with  flaccid  blisters  positive 
tzanck smear, and positive Nikolsky sign. Direct immunofluorescence showed 
features of pemphigus vulgaris. A few weeks later, she presented with clinical 
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features suggestive of bullous pemphigoid. Tzanck smear was negative and 
histopathology showed subepidermal bulla. An indirect immunofluorescence 
study found IgG against intercellular cement substance in 1:80 dilutions. Thus, 
a final diagnosis of pemphigus vulgaris was made. 
Naveed Sami et al66, have reported a series of 13 patients who initially 
presented  with  clinical  and  immunofluorescence  features  of  bullous 
pemphigoid, who subsequently demonstrated co-existent DIF and IIF features 
of  bullous  pemphigoid  and  pemphigus  vulgaris.  Cholzelski  et  al67,  and 
Leibovici et al have described similar patients. However, our patient initially 
presented with pemphigus vulgaris, and then progressed to manifest a bullous 
pemphigoid  –  like  presentation.  The  patient  is  on  dexamethasone  – 
cyclophosphamide pulse therapy, and is being followed up. 
Associations 
  In  our  study,  the  commonest  coexisting  disease  was  non-insulin 
dependent  diabetes  mellitus  in  6  patients  (18.75%),  and hypertension  in  2 
patients (6.25%). Ischaemic heart disease was associated in one patient.
A 27 years old female patient who presented bullous pemphigoid of 1 
month  duration,  was  diagnosed  to  have  multiple  liver  secondaries  in 
ultrasonography.  However,  the  patient  died  before  the  primary  malignancy 
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could  be  established.  Association  of  bullous  pemphigoid  with  internal 
malignancies has been described in earlier studies by Ogawa et al62.
A history  of  diclofenac  ingestion  prior  to  the  onset  of  linear  IgA 
dermatosis  was  elicited  in  a  16  yr  old  male.  Similar  findings  have  been 
reported in earlier studies.
In  contrast  to  earlier  studies  by  Callen  JP  et  al63,  and  et  al,  no 
association with other autoimmune diseases could be established in our study. 
Rare and interesting disease 
A 60 yrs old male who presented tense bullae initially, and vegetative 
lesions subsequently, was diagnosed as a case of pemphigoid vegetans, based 
on the following findings. 
1. Vegetative lesions 
2. Marked acanthosis with subepidermal blister and eosinophils 
3. Linear BMZ deposits of C3 
Winkelman et  al  have reported a case  of  pemphigoid vegetans  with 
findings similar to our case. 
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SUMMARY
32  patients,  diagnosed  with  autoimmune  vesiculobullous  diseases, 
based  on  history,  clinical  features,  cytology,  histopathology,  and 
immunofluorescence were included in the study. 
Incidence 
The incidence was 1.7:10,000, among 1,92,750 patients who attended 
the skin OPD during the period of study. 
Sex
13 patients were male (40.6%) and 19 patients were female (59.4%). 
The male:female ratio was approximately 2:3.
Age
78.1% of the patients were between 21-60 years of age. 
Morphology and distribution 
The morphology of lesions and their distribution were concordant with 
those described in the literature. Oral mucosal involvement and flaccid bullae 
was noted in 100% of the cases of pemphigus vulgaris. Tense bullae (100%) 
and targetoid  lesions  (62.5%) were  the  commonest  lesions  seen in  bullous 
pemphigoid. 
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Nikolsky sign and Asboe-Hansen sign 
These signs were positive in 100% of the pemphigus patients, and one 
patient with paraneoplstic bullous pemphigoid. 
Tzanck smear 
Acantholytic  cells  were  demonstrated  in  100% cases  of  pemphigus. 
Eosinophils could be seen in 75% of bullous pemphigoid cases multinucleated 
cells were seen in 23% of pemphigus vulgaris patients. 
Histopathology 
Histopathological  features  consistent  with  pemphigus  vulgaris  were 
seen  in  13  patients,  pemphigus  foliaceus  in  2  patients,  pemphigus 
erythematosus  in  3  patients,  IgA  pemphigus  in  one  patient,  bullous 
pemphigoid in 8 patients, linear IgA dermatosis in one patient, and bullous 
SLE, acute LE and pemphigoid vegetans in one patient each. One patient who 
was diagnosed as cicatricial pemphigoid based on histopathology, was later 
diagnosed as linear IgA dermatosis based on DIF. 
Immunofluorescence 
 Based  on  direct  immunofluorescence  findings,  a  diagnosis  of 
pemphigus  vulgaris  was  made  in  13  patients,  pemphigus  foliaceus  in  2 
patients,  pemphigus  erythematosus  in  1  patient,  bullous  pemphigoid  in  8 
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patients,  linear  IgA dermatosis  in  2  patients  acute  cutaneous  LE  in  one, 
bullous SLE in one patient and pemphigoid vegetans in one patient. 
One patient who had DIF findings of pemphigus vulgaris initially and 
bullous  pemphigoid  2  months  later,  was  subjected  to  indirect 
immunofluorescence and was finally diagnosed as pemphigus vulgaris. 
Association 
   Non insulin dependent diabetes mellitus was the commonest associated 
disease, seen in 18.75% cases, followed by hypertension (6.25%), ischaemic 
heart disease (3%), internal malignancy (3%) and diclofenac ingestion (3%).
52
CONCLUSION
1. Autoimmune  vesiculobullous  diseases  were  rare  skin  diseases 
comprising  only  a  very  small  percentage  of  patients  attending  skin 
OPD.
2. Pemphigus  vulgaris  was  the  most  common  autoimmune 
vesiculobullous disease, followed by bullous pemphigoid. 
3. Pemphigus vulgaris occurred more commonly in females. 
4. Majority of the patients were between 21-60 yrs of age. 
5. Tzanck smear is a useful bedside tool which points towards the final 
diagnosis. 
6. Histopathological examination is of paramount importance in arriving 
at the diagnosis. 
7. Direct immunofluorescence technique is a useful supplement to routine 
histopathology, and may prove to be of diagnostic value and therapeutic 
significance in selected cases. 
8. Indirect  immunofluorescence  is  helpful  in  arriving  at  the  correct 
diagnosis in selected cases.  
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PROFORMA
Name :
Age / Sex: 
Occupation:  
Income: 
S/E status: 
Address:
General history
d) HT / DM : 
e) PT / Heart Disease :
f) Malignancy :
g) Smoking / Alcohol :
h) Precipitating factors :
i. Drugs :
j. Infection :
k. Diet :
l. Trauma :
m. Sweating :
n. Sun exposure :
o) Oral / Genital herpes:
Family history
p) Marital status :
q) Children :
r) Obstetric history :
s) P/S Done or not :
t) Menstrual history :
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u) H/o other auto immune 
Disease in the patient :   
v) H/O auto immune
diseases in relatives : 
H/O vesiculobullous disease
w) Date of onset :
x) Site of first lesion :
(mucosal / skin)
y) Morphology of first 
Skin lesion and it’s
Evolution :
z) Treatment received :
aa) Date of registration at GRH :
bb) Number of acute exacerbations: 
Onset Duration PPt. factors Treatment 
Condition on First Visit
4. General Condition 
cc) wt :
dd) CVS :
ee) RS :
ff) Abd :
gg) Others :
 Oral Lesion 
 Active Skin lesions 
hh) Number of bullae :
ii) Distribution – groups / discrete / along lines of trauma:
jj) Tense/flaccid :
kk) Contents – clear / pustular / hemorrhagic:
ll) Nikolsky sign & bulla spread sign:
mm) Are of erosions :
nn) Symptoms :
4. Healing skin lesions 
oo) Hyper / hypo pigmentation: • Scarring :
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pp) Milla : • Peripheral extension :
Investigations
LFT
 
RFT
Sr. Electrolytes 
Hemogram 
ECG
Tzanck 
Biopsy 
DIF
USG abdomen 
Others 
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NAME: 
Date Complaints
New 
lesions 
skin / 
mucosa
Persisten
t lesion 
oral/ 
scalp/ 
skin
Treatment 
DCP / 
others Wt. BP Urine ASD TC DC Hb 
Blood 
USC
LFT / 
Tzanck 
/ Others
Remarks / 
Blister free 
period / 
menstrual 
history
KEY TO MASTER CHART
ul = upper limb ll = lower limb 
tghs = thighs ax = axilla 
sc = scalp trnk = trunk 
gen = genital conj = conjunctival 
P = present / positive A = absent 
N = negative PV = pemphigus vulgaris 
BP = bullous pemphigoid PF = pemphigus foliaceus 
PE = pemphigus erythematosus LAD = Linear IgA dermatosis 
PgV = Pemphigoid vegetans 
EBA = epidermolysis bullosa acquisita 
DLE = Discoid lupus erythematosus 
BSLE = bullous SLE 
PNP = paraneoplastic pemphigus 
NIDDM = non – insulin dependant diabetes mellitus 
HT = hypertension 
ACA = acantholytic call 
Neu = neutrophil 
EOS = eosinophil 
Sub epi = sub epidermal 
64
